The place for the tricyclic antidepressants in the treatment of depression

References

• Burrows GD, Norman TR. Depression. Principles of contemporary management. Current Therapeutics 1997; 38: 19–27
   Google Scholar
• Harrison G. New or old antidepressants? New is better. British Medical Journal 1994; 309: 1280–1282
   PubMed Web of Science ®Google Scholar
• Beerworth EE, Tiller JWG. Liability in prescribing choice: the example of the antidepressants. Australian and New Zealand Journal of Psychiatry 1998; 32: 560–566
   PubMed Web of Science ®Google Scholar
• Parker G, Hadzi‐Pavlovic D, Boyce P. Endogenous depression as a construct: a quantitative analysis of the literature and a study of clinician judgements. Australian and New Zealand Journal of Psychiatry 1989; 23: 357–368
   PubMed Web of Science ®Google Scholar
• Quality Assurance Project. A treatment outline for depressive disorder. Australian and New Zealand Journal of Psychiatry 1983; 17: 129–146
   PubMed Web of Science ®Google Scholar
• Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health treatment of depression collaborative research program: general effectiveness of treatments. Archives of General Psychiatry 1989; 46: 971–982
   PubMed Web of Science ®Google Scholar
• Persons JB, Thase ME, Crits‐christoph P. The role of psychotherapy in the treatment of depression. Archives of General Psychiatry 1996; 53: 283–290
   PubMed Web of Science ®Google Scholar
• Mynors‐Wallis LM, Gath DH, Lloyd‐Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. British Medical Journal 1995; 310: 441–445
   PubMed Web of Science ®Google Scholar
• Gloaguen V, Cottraux J, Cucherat M, Blackburn I ‐M. A meta‐analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders 1998; 49: 59–72
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for major depressive disorder in adults. American Journal of Psychiatry 1993; 150(Suppl. 4)1–26
   PubMed Web of Science ®Google Scholar
• Peselow E, Sanfilipo M, DiFiglia C, Fieve R. Melancholic/endogenous depression and response to somatic treatment and placebo. American Journal of Psychiatry 1992; 149: 1324–1334
   PubMed Web of Science ®Google Scholar
• Song F, Freemantle N, Sheldon T, House A, Watson P, Long A, Mason J. Selective serotonin reuptake inhibitors: meta‐analysis of efficacy and acceptability. British Medical Journal 1993; 306: 683–687
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic anti‐depressants: a meta‐analysis. International Clinical Psychopharmacology 1995; 9(Suppl. 4)33–40
   PubMed Web of Science ®Google Scholar
• Lima MS, Moncrieff J. A comparison of drugs versus placebo for the treatment of dysthymia: a systematic review. Oxford 1998, Cochrane Database of Systematic Reviews. Issue 4
   Google Scholar
• Anderson IM, Tomenson BM. The efficacy of selective serotonin re‐uptake inhibitors in depression: a meta‐analysis of studies against tricyclic antidepressants. Journal of Psychopharmacology 1994; 8: 238–249
   PubMed Web of Science ®Google Scholar
• Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta‐analysis and investigation of heterogeneity. British Journal of Psychiatry 1997; 170: 120–127
   PubMed Web of Science ®Google Scholar
• Joffe R, Sokolov S, Streiner D. Antidepressant treatment of depression: a metanalysis. Canadian Journal of Psychiatry 1998; 41: 613–616
   Web of Science ®Google Scholar
• Garattini S, Barbui C, Saraceno B. Antidepressant agents: from tricyclics to serotonin uptake inhibitors. Psychological Medicine 1998; 28: 1169–1178
   PubMed Web of Science ®Google Scholar
• Kasper S. Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine. Journal of Clinical Psychopharmacology 1997; 17(Suppl. 2)S19–S28
   Web of Science ®Google Scholar
• Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. American Journal of Psychiatry 1994; 151: 1735–1739
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Gram LF, Kragh‐Sorensen P, Bech P, Reisby N, Bolwig TG. Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group. Psychopharmacological Services 1993; 10: 190–198
   PubMedGoogle Scholar
• Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Journal of Affective Disorders 1990; 18: 289–299
   PubMed Web of Science ®Google Scholar
• Danish University Antidepressant Group. Moclobemide: a reversible MAO‐A‐inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Journal of Affective Disorders 1993; 28: 105–116
   PubMed Web of Science ®Google Scholar
• Perry PJ. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of Affective Disorder 1996; 39: 1–6
   PubMed Web of Science ®Google Scholar
• Tignol J, Stoker MJ, Dunbar GC. Paroxetine in the treatment of melancholia and severe depression. International Clinical Psychopharmacology 1992; 7: 91–94
   PubMed Web of Science ®Google Scholar
• Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta‐analysis. British Medical Journal 1995; 310: 1433–1438
   PubMed Web of Science ®Google Scholar
• Martin RM, Hilton SR, Kerry SM, Richards NM. General practitioners' perceptions of the tolerability of anti‐depressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants. British Medical Journal 1997; 314: 646–651
   PubMed Web of Science ®Google Scholar
• Trindale E, Menon D. Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part 1. Evaluation of the clinical literature. Canadian Coordinating Office for Health Technology Assessment, Ottawa 1997, Report 3E
   Google Scholar
• Mitchell PB. The new antidepressants: a guide for GPs. Modern Medicine 1994; 37: 16–20
   Google Scholar
• Zajecka J, Mitchell S, Fawcett J. Treatment‐emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacology Bulletin 1997; 33: 755–760
   PubMed Web of Science ®Google Scholar
• Martin TG. Serotonin syndrome. Annals of Emergency Medicine 1996; 28: 520–526
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, DeVane CL, Pollock BG. Newer anti‐depressants and the cytochrome P450 system. American Journal of Psychiatry 1996; 153: 311–320
   PubMed Web of Science ®Google Scholar
• Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. Journal of Clinical Psychopharmacology 1996; 16: 356–362
   PubMed Web of Science ®Google Scholar
• Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. British Medical Journal 1995; 310: 221–224
   PubMed Web of Science ®Google Scholar
• Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. British Journal of Psychiatry 1998; 172: 35–37
   PubMed Web of Science ®Google Scholar
• Isacsson G, Holmgren P, Wasserman D, Bergman U. Authors' reply. British Medical Journal 1994; 308: 916
   PubMed Web of Science ®Google Scholar
• Edwards JG. Suicide and antidepressants. British Medical Journal 1995; 310: 205–206
   PubMed Web of Science ®Google Scholar
• Dudley MJ, Kelk NJ, Florio TM, Howard JP, Waters BGH. Suicide among young Australians, 1964–1993, an interstate comparison of metropolitan and rural trends. Medical Journal of Australia 1998; 169: 77–80
   PubMed Web of Science ®Google Scholar
• Buckley NA, Whyte IM, Dawson AH, McManus PR, Ferguson NW. Correlations between prescriptions and drugs taken in self‐poisoning. Medical Journal of Australia 1995; 162: 194–197
   PubMed Web of Science ®Google Scholar